• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Co-infection of ST2 carbapenem-resistant Acinetobacter baumannii with SARS-CoV-2 in the patients admitted to a Tehran tertiary referral hospital.德黑兰一家三级转诊医院收治患者中耐碳青霉烯类鲍曼不动杆菌ST2与新型冠状病毒的合并感染
BMC Infect Dis. 2021 Sep 8;21(1):927. doi: 10.1186/s12879-021-06642-2.
2
Accumulation of Antibiotic Resistance Genes in Carbapenem-Resistant Isolates Belonging to Lineage 2, Global Clone 1, from Outbreaks in 2012-2013 at a Tehran Burns Hospital.2012-2013 年德黑兰烧伤医院暴发疫情中属于 2 谱系全球克隆 1 型的碳青霉烯类耐药分离株中抗生素耐药基因的积累。
mSphere. 2020 Apr 8;5(2):e00164-20. doi: 10.1128/mSphere.00164-20.
3
The context of bla gene in Iraqi carbapenem-resistant Acinetobacter baumannii isolates belonging to global clone 1 and global clone 2.伊拉克碳青霉烯类耐药鲍曼不动杆菌分离株 bla 基因的全球克隆 1 和全球克隆 2 背景。
BMC Res Notes. 2024 Oct 8;17(1):300. doi: 10.1186/s13104-024-06890-w.
4
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.分析 ICU 患者下呼吸道感染的鲍曼不动杆菌分离株的表型和分子特征。
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
5
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.埃及一家三级护理医院耐碳青霉烯鲍曼不动杆菌的分子流行病学:blaOXA-23的克隆传播
Microb Drug Resist. 2018 Apr;24(3):269-277. doi: 10.1089/mdr.2017.0057. Epub 2017 Aug 7.
6
Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii.耐碳青霉烯鲍曼不动杆菌临床分离株中β-内酰胺酶基因的分子特征分析
Ann Clin Microbiol Antimicrob. 2017 Nov 16;16(1):75. doi: 10.1186/s12941-017-0248-3.
7
Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Strains Recovered from Chilean Hospitals Reveals Lineages Specific to South America and Multiple Routes for Acquisition of Antibiotic Resistance Genes.从智利医院分离的耐碳青霉烯鲍曼不动杆菌的基因组分析揭示了南美的特有谱系和获得抗生素耐药基因的多种途径。
Microbiol Spectr. 2022 Oct 26;10(5):e0246322. doi: 10.1128/spectrum.02463-22. Epub 2022 Sep 26.
8
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.中国黑龙江省东部 ICU 爆发携带碳青霉烯酶 OXA-23 的耐碳青霉烯鲍曼不动杆菌。
BMC Infect Dis. 2019 May 22;19(1):452. doi: 10.1186/s12879-019-4073-5.
9
Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran.伊朗德黑兰产 OXA-24 和 -58 型碳青霉烯类耐药鲍曼不动杆菌分离株的克隆相关性和耐药特征。
J Appl Microbiol. 2019 Nov;127(5):1421-1429. doi: 10.1111/jam.14409. Epub 2019 Sep 10.
10
Comparative Analysis of Carbapenem-Resistant Sequence Types in Southern Brazil: From the First Outbreak (2007-2008) to the Endemic Period (2013-2014).巴西南部碳青霉烯类耐药序列型的比较分析:从第一次暴发(2007-2008 年)到流行期(2013-2014 年)。
Microb Drug Resist. 2019 May;25(4):538-542. doi: 10.1089/mdr.2018.0262. Epub 2018 Nov 8.

引用本文的文献

1
infection in critically ill patients with COVID-19 from Tehran, Iran: the prevalence, antimicrobial resistance patterns and molecular characteristics of isolates.来自伊朗德黑兰的新冠肺炎危重症患者的感染情况:分离株的患病率、抗菌药物耐药模式及分子特征
Front Cell Infect Microbiol. 2025 Jan 30;14:1511122. doi: 10.3389/fcimb.2024.1511122. eCollection 2024.
2
Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies.鲍曼不动杆菌生物膜形成和抗菌耐药性的协同调控:从机制到治疗策略。
Eur J Clin Microbiol Infect Dis. 2023 Dec;42(12):1405-1423. doi: 10.1007/s10096-023-04677-8. Epub 2023 Oct 28.
3
Occurrence of Acinetobacter baumannii genomic resistance islands (AbGRIs) in Acinetobacter baumannii strains belonging to global clone 2 obtained from COVID-19 patients.从 COVID-19 患者中获得的属于全球克隆 2 的鲍曼不动杆菌菌株中出现的鲍曼不动杆菌基因组耐药岛(AbGRIs)。
BMC Microbiol. 2023 Aug 24;23(1):234. doi: 10.1186/s12866-023-02961-3.
4
Bacterial coinfection and antibiotic resistance in hospitalized COVID-19 patients: a systematic review and meta-analysis.COVID-19 住院患者的细菌合并感染和抗生素耐药性:系统评价和荟萃分析。
PeerJ. 2023 Apr 26;11:e15265. doi: 10.7717/peerj.15265. eCollection 2023.
5
Genomic Comparative Analysis of Two Multi-Drug Resistance (MDR) Clinical Strains Assigned to International Clonal Lineage II Recovered Pre- and Post-COVID-19 Pandemic.对两株属于国际克隆谱系II的多重耐药(MDR)临床菌株进行基因组比较分析,这两株菌株分别在新冠疫情之前和之后分离得到。
Biology (Basel). 2023 Feb 24;12(3):358. doi: 10.3390/biology12030358.
6
Virulence potential of multidrug-resistant isolates from COVID-19 patients on mechanical ventilation: The first report from Serbia.新型冠状病毒肺炎机械通气患者多重耐药菌株的毒力潜力:来自塞尔维亚的首份报告。
Front Microbiol. 2023 Feb 6;14:1094184. doi: 10.3389/fmicb.2023.1094184. eCollection 2023.
7
COVID-19 Clinical Profiles and Fatality Rates in Hospitalized Patients Reveal Case Aggravation and Selective Co-Infection by Limited Gram-Negative Bacteria.COVID-19 临床特征和住院患者病死率揭示了病例恶化和有限革兰氏阴性菌的选择性合并感染。
Int J Environ Res Public Health. 2022 Apr 26;19(9):5270. doi: 10.3390/ijerph19095270.
8
The Collateral Effects of COVID-19 Pandemic on the Status of Carbapenemase-Producing Pathogens.**新冠疫情对产碳青霉烯酶病原体状况的附带影响**。
Front Cell Infect Microbiol. 2022 Mar 17;12:823626. doi: 10.3389/fcimb.2022.823626. eCollection 2022.

本文引用的文献

1
: An Ancient Commensal with Weapons of a Pathogen.一种带有病原体武器的古老共生菌。
Pathogens. 2021 Mar 24;10(4):387. doi: 10.3390/pathogens10040387.
2
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt.新冠病毒肺炎患者严重程度及合并感染抵抗情况的预测因素:上埃及地区的首份报告
Infect Drug Resist. 2020 Oct 5;13:3409-3422. doi: 10.2147/IDR.S272605. eCollection 2020.
3
COVID-19, gram-negative sepsis and a pleuro-peritoneal leak.新型冠状病毒肺炎、革兰氏阴性菌败血症和胸膜腹膜漏。
Pan Afr Med J. 2020 Sep 5;37:21. doi: 10.11604/pamj.2020.37.21.25311. eCollection 2020.
4
Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.评估 ICU 收治的 COVID-19 患者呼吸道的细菌合并感染。
BMC Infect Dis. 2020 Sep 1;20(1):646. doi: 10.1186/s12879-020-05374-z.
5
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy.FDA 批准了具有治疗 SARS-CoV-2(COVID-19)潜力的药物。
Drug Resist Updat. 2020 Dec;53:100719. doi: 10.1016/j.drup.2020.100719. Epub 2020 Jul 15.
6
Carbapenemases: Transforming into a Yet More Dangerous Menace.碳青霉烯酶:将 转变为更危险的威胁。
Biomolecules. 2020 May 6;10(5):720. doi: 10.3390/biom10050720.
7
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.欧洲首批 COVID-19 病例的临床和病毒学数据:一项病例系列研究。
Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27.
8
COVID-19 battle during the toughest sanctions against Iran.在对伊朗最严厉制裁期间的新冠疫情防控战。
Lancet. 2020 Mar 28;395(10229):1035-1036. doi: 10.1016/S0140-6736(20)30668-1. Epub 2020 Mar 18.
9
Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience.COVID-19 疫情期间的插管与通气:武汉的经验。
Anesthesiology. 2020 Jun;132(6):1317-1332. doi: 10.1097/ALN.0000000000003296.
10
Emergence, molecular mechanisms and global spread of carbapenem-resistant .耐碳青霉烯肠杆菌科细菌的出现、分子机制和全球传播。
Microb Genom. 2019 Oct;5(10). doi: 10.1099/mgen.0.000306.

德黑兰一家三级转诊医院收治患者中耐碳青霉烯类鲍曼不动杆菌ST2与新型冠状病毒的合并感染

Co-infection of ST2 carbapenem-resistant Acinetobacter baumannii with SARS-CoV-2 in the patients admitted to a Tehran tertiary referral hospital.

作者信息

Abdollahi Alireza, Aliramezani Amir, Salehi Mohammadreza, Norouzi Shadehi Mahsa, Ghourchian Sedighe, Douraghi Masoumeh

机构信息

Department of Pathology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

Department of Infectious Disease, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

BMC Infect Dis. 2021 Sep 8;21(1):927. doi: 10.1186/s12879-021-06642-2.

DOI:10.1186/s12879-021-06642-2
PMID:34496774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8423834/
Abstract

BACKGROUND

Carbapenem-resistant Acinetobacter baumannii (CRAB) is among the most concerning cause of healthcare-associated infections (HAI) due to its high level of antibiotic resistance and high mortality. In the era of the COVID-19 pandemic, the key priority of infection control committees is to contain the dissemination of antibiotic resistant Gram-negative bacteria. Here, we aimed to timely recognize the emergence of CRAB in COVID-19 cases admitted to the wards of a tertiary referral hospital and to identify the genetic relatedness of the isolates.

METHODS

From 30 March to 30 May 2020, a total of 242 clinical samples from COVID-19 cases were screened for CRAB isolates using standard microbiologic and antibiotic susceptibility tests. The PCRs targeting oxa23, oxa24, oxa58, bla and bla genes were performed. Two multiplex PCRs for identifying the global clones (GC) of A. baumannii were also performed. The sequence type of CRABs was determined using Institut Pasteur (IP) multilocus sequence typing (MLST) scheme.

RESULTS

Eighteen CRAB isolates were recovered from COVID-19 patients with the mean age of 63.94 ± 13.8 years. All but 4 COVID-19 patients co-infected with CRAB were suffering from an underlying disease. Death was recorded as the outcome in ICUs for 9 (50%) COVID-19 patients co-infected with CRAB. The CRAB isolates belong to GC2 and ST2 and carried the oxa23 carbapenem resistance gene.

CONCLUSION

This study demonstrated the co-infection of CRAB isolates and SARS-CoV-2 in the patients admitted to different ICUs at a referral hospital in Tehran. The CRAB isolates were found to belong to ST2, share the oxa23 gene and to have caused several outbreaks in the wards admitting COVID-19 patients.

摘要

背景

耐碳青霉烯类鲍曼不动杆菌(CRAB)因其高度的抗生素耐药性和高死亡率,成为医疗保健相关感染(HAI)最令人担忧的病因之一。在新冠疫情时代,感染控制委员会的首要任务是遏制抗生素耐药革兰氏阴性菌的传播。在此,我们旨在及时识别三级转诊医院病房收治的新冠肺炎病例中CRAB的出现情况,并确定分离株的遗传相关性。

方法

2020年3月30日至5月30日,共对242份新冠肺炎病例的临床样本进行筛查,采用标准微生物学和抗生素敏感性试验检测CRAB分离株。进行了针对oxa23、oxa24、oxa58、bla和bla基因的聚合酶链反应(PCR)。还进行了两个用于鉴定鲍曼不动杆菌全球克隆(GC)的多重PCR。使用巴斯德研究所(IP)多位点序列分型(MLST)方案确定CRAB的序列类型。

结果

从新冠肺炎患者中分离出18株CRAB,患者平均年龄为63.94±13.8岁。除4例新冠肺炎合并CRAB感染患者外,其余患者均患有基础疾病。在重症监护病房(ICU)中,9例(50%)新冠肺炎合并CRAB感染患者的结局为死亡。CRAB分离株属于GC2和ST2,携带oxa23碳青霉烯耐药基因。

结论

本研究证明了德黑兰一家转诊医院不同ICU收治的患者中存在CRAB分离株与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的合并感染。发现CRAB分离株属于ST2,共享oxa23基因,并在收治新冠肺炎患者的病房中引发了多次暴发。